totrombopag
Term · Oncology and biomedicine · MLC-T-ONC-017279
An orally available small molecule agonist of the platelet thrombopoietin (TPO) receptor (TPOR; MPL), with potential megakaryopoiesis stimulating activity. Upon administration, totrombopag mimics TPO and binds to TPOR. This stimulates TPOR and leads to the proliferation and differentiation of megakaryocytes in the bone marrow. This increases the production of blood platelets and decreases bleeding in thrombocytopenic patients. TPOR is a cytokine receptor and member of the hematopoietin receptor superfamily.
| Identifier | MLC-T-ONC-017279 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | thrombopoietin receptor agonist LGD-4665; TPO mimetic LGD-4665 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017279",
"term": "totrombopag",
"field": "Oncology and biomedicine",
"definition": "An orally available small molecule agonist of the platelet thrombopoietin (TPO) receptor (TPOR; MPL), with potential megakaryopoiesis stimulating activity. Upon administration, totrombopag mimics TPO and binds to TPOR. This stimulates TPOR and leads to the proliferation and differentiation of megakaryocytes in the bone marrow. This increases the production of blood platelets and decreases bleeding in thrombocytopenic patients. TPOR is a cytokine receptor and member of the hematopoietin receptor superfamily.",
"synonyms": [
"thrombopoietin receptor agonist LGD-4665",
"TPO mimetic LGD-4665"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/totrombopag/"
}
Record 16,553 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.